| Gregory Robert Owens, MD | |
|
500 Sw Ramsey Ave, Grants Pass, OR 97527-5554 | |
| (541) 472-7000 | |
| Not Available |
| Full Name | Gregory Robert Owens |
|---|---|
| Gender | Male |
| Speciality | Emergency Medicine |
| Location | 500 Sw Ramsey Ave, Grants Pass, Oregon |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003044652 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | 4301094366 (Michigan) | Primary |
| Entity Name | Asante Three Rivers Medical Center Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1801891809 PECOS PAC ID: 9931197993 Enrollment ID: O20040506000367 |
News Archive
Transgenomic, Inc. today announced the global, commercial availability of CRC RAScan, a new mutation detection test to screen patients with metastatic colorectal cancer for RAS mutations (KRAS and NRAS).
We laugh when we see Homer Simpson falling asleep while driving, while in church, and while even operating the nuclear reactor. In reality though, narcolepsy, cataplexy, and rapid eye movement (REM) sleep behavior disorder are all serious sleep-related illnesses.
Aches and pains are common during pregnancy, yet many women dismiss them as a normal part of carrying a baby.
Profil Institute for Clinical Research, Inc., a company leading the industry in early phase clinical trials for diabetes and obesity, and Rosa & Co. LLC, a drug development advisory firm with expertise in drug-disease modeling and simulation, jointly announced today a strategic alliance to offer Profil Institute customers use of Rosa's modeling technology to simulate disease physiology, drug action, patient variability, and trial outcomes for their early phase clinical development programs.
Today, The Lancet Neurology published positive results from a sub-group analysis of the landmark Randomized Evaluation of Long-Term Anticoagulant Therapy (RE-LY®) trial - the largest atrial fibrillation (AF) outcomes trial ever completed (18,113 patients in 44 countries worldwide). The new findings fully support the convincing results from the RE-LY® trial and show that AF patients with previous stroke or transient ischemic attack (TIA) may benefit substantially from treatment with dabigatran etexilate.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Gregory Robert Owens, MD Po Box 4749, Medford, OR 97501-0227 Ph: (541) 789-5516 | Gregory Robert Owens, MD 500 Sw Ramsey Ave, Grants Pass, OR 97527-5554 Ph: (541) 472-7000 |
News Archive
Transgenomic, Inc. today announced the global, commercial availability of CRC RAScan, a new mutation detection test to screen patients with metastatic colorectal cancer for RAS mutations (KRAS and NRAS).
We laugh when we see Homer Simpson falling asleep while driving, while in church, and while even operating the nuclear reactor. In reality though, narcolepsy, cataplexy, and rapid eye movement (REM) sleep behavior disorder are all serious sleep-related illnesses.
Aches and pains are common during pregnancy, yet many women dismiss them as a normal part of carrying a baby.
Profil Institute for Clinical Research, Inc., a company leading the industry in early phase clinical trials for diabetes and obesity, and Rosa & Co. LLC, a drug development advisory firm with expertise in drug-disease modeling and simulation, jointly announced today a strategic alliance to offer Profil Institute customers use of Rosa's modeling technology to simulate disease physiology, drug action, patient variability, and trial outcomes for their early phase clinical development programs.
Today, The Lancet Neurology published positive results from a sub-group analysis of the landmark Randomized Evaluation of Long-Term Anticoagulant Therapy (RE-LY®) trial - the largest atrial fibrillation (AF) outcomes trial ever completed (18,113 patients in 44 countries worldwide). The new findings fully support the convincing results from the RE-LY® trial and show that AF patients with previous stroke or transient ischemic attack (TIA) may benefit substantially from treatment with dabigatran etexilate.
› Verified 4 days ago
Michael F. Mccaskill, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 436 Timber Lane, Grants Pass, OR 97526 Phone: 541-474-2767 | |
Martin P Hill, MD Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 500 Sw Ramsey Ave., Grants Pass, OR 97527 Phone: 541-472-7000 | |
Eric J Loeliger, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 500 Sw Ramsey Avenue, Grants Pass, OR 97527 Phone: 541-472-7000 Fax: 701-323-5709 | |
Douglas J Howard, MD Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 500 S.w. Ramsey Avenue, Grants Pass, OR 97527 Phone: 541-472-7000 | |
Peter P Rist, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 500 Sw Ramsey Ave., Grants Pass, OR 97527 Phone: 541-472-7000 | |
Dr. Christopher K David, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 500 Sw Ramsey Ave, Grants Pass, OR 97527 Phone: 541-472-7000 |